Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin

Human Genetics

Volumn 97, Issue 5, 1996, Pages 638-641

  De Vitis, Lucia Rosaria ^a   Tedde, Andrea ^a   Vitelli, Francesca ^a   Ammannati, Franco ^b   Mennonna, Pasquale ^b   Bono, Paolo ^c   Grammatico, Barbara ^d   Grammatico, Paola ^d   Radice, Paolo ^e   Bigozzi, Umberto ^a   Montali, Enrico ^a   Papi, Laura ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Neurosurgery Unit   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARCINOGENESIS; CHROMOSOME 22; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOMA; MERKEL CELL TUMOR; NEURAL CREST; NEURILEMOMA; NEUROECTODERM TUMOR; NEUROFIBROMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 22; EPENDYMOMA; EXONS; GENES, NEUROFIBROMATOSIS 2; GLIOMA; HUMANS; MELANOMA; MENINGEAL NEOPLASMS; MENINGIOMA; MUTATION; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; NEUROMA, ACOUSTIC; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REFERENCE VALUES;

EID: 13344269669     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050108     Document Type: Article

References (29)

1. Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y (1994) Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3 : 565-568
2. Bianchi AB, Hara T, Ramesh V, Gao J, Lein-Szanto AJP, Monn F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, Kley N (1994) Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genet 6 : 185-192
3. Bijlsma EK, Merel P, Bosh DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJM (1994) Analysis of mutations in the SCH gene in schwannomas. Genes Chromosomes Cancer 11 : 7-14
4. Bourn D, Carter S, Mason S, Gareth D, Evans R, Strachan T (1994) Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet 3 : 813-816
5. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, Montali E, Papi L (1996) Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 97 : 632-637
6. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J Med Genet 29 : 841-846
7. Harnett PR, Kearsley JH, Hayward NK, Dracopoli NC: Kefford RF (1991) Loss of allelic heterozygosity on distal chromosome 1p in Merkel cell carcinoma. A marker of neural crest origin? Cancer Genet Cytogenet 54 : 109-133
8. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER (1994) Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 3 : 347-350
9. Jacoby LB, MacCollin M, Louis DN, Mohoney T, Rubio M-P, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, Gusella JF (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3 : 413-419
10. James CD, Carlborm E, Dumanski JP, Hansen M, Nordenskjold M, Collins P, Cavenee WK (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res 48 : 5546-5551
11. Kamb A, Gruis AG, Weaver-Feldhause J, Lui Q, Harshman K, Tavtigan SV, Stocken D, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 : 436-440
12. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, Drunen A E van, Bootsma D, Koper JW, Avezaat CJJ, Kley N, Zwarthoff EC (1994) Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54 : 1022-1029
13. Malkin D (1994) p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1198 : 197-213
14. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature 368 : 753-756
15. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U (1995) Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95 : 347-351
16. Pykett MJ, Murhpy M, Harnish PR, George DL (1994) The neurofibromatosis type 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum Mol Genet 3 : 559-564
17. Rey JA, Bello MJ, Jimenez-Lara AM, Vaquero J, Kusak ME, De Campos JM, Sarasa JL, Pestana A (1992) Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer 51 : 703-706
18. Rouleau GA, Merel P, Lutchman M, Sanson M, Zuchman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, Jong P de, Parry D, Roswell E, Aurias A, Delattre O, Thomas G (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363 : 515-521
19. Rubio M-P, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, Deimling A von, Gusella JF, Louis DN (1994) Analysis of the neurofibromatosis 2 gene in human epedymomas and astrocytomas. Cancer Res 54 : 45-47
20. Russel DS, Rubinstein LJ (1989) Tumours of the meninges and related tissues. In: Russel DS, Rubinstein LJ (eds) Pathology of tumours of the nervous system. 5th edn. Arnold, London, pp 449-532
21. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau GA (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 6 : 180-184
22. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst S-M (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3 : 885-891
23. Sekido Y, Pass HI, Bader S, Mew DJY, Christman MF, Gazdar AF, Minna JD (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55 : 1227-1231
24. Tang CK, Toker C (1978) Trabecular carcinoma of the skin: an ultrastructural study. Cancer 42 : 2311-2321
25. Toker C (1972) Trabecular carcinoma of the skin. Arch Dermatol 105 : 107-110
26. Trofatter JA, MacCollin MM, Rutter JL, Murrel JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the Neurofibromatosis 2 tumor suppressor. Cell 72 : 791-800
27. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3 : 147-151
28. Volgestein B, Kinzler KW (1993) The multistep nature of cancer. Trends Genet 4 : 138-141
29. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M (1995) Homozygous deletion of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55 : 20-23